Hussman Strategic Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.76M | Sell |
|
|||||
|
2024
Q4 | $2M | Buy |
|
|||||
|
2024
Q3 | $1.75M | Buy |
|
|||||
|
2024
Q2 | $933K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $250K | Hold |
|
|||||
|
2022
Q4 | $358K | Hold |
|
|||||
|
2022
Q3 | $364K | Hold |
|
|||||
|
2022
Q2 | $572K | Hold |
|
|||||
|
2022
Q1 | $751K | Hold |
|
|||||
|
2021
Q4 | $862K | Hold |
|
|||||
|
2021
Q3 | $961K | Hold |
|
|||||
|
2021
Q2 | $922K | Hold |
|
|||||
|
2021
Q1 | $1.21M | Buy |
|
|||||
|
2020
Q4 | $562K | Buy |
|
|||||
|
2020
Q3 | $396K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.77M | Sell |
|
|||||
|
2018
Q2 | $3.28M | Buy |
|